Home › Funds › Cutter & CO Brokerage, Inc. › REGN

Cutter & CO Brokerage, Inc. position in REGN

REGENERON PHARMACEUTICALS · Health Care

Cutter & CO Brokerage, Inc. reported holding 10,838 shares of REGN (REGENERON PHARMACEUTICALS) in its Q1 2025 13F filing — a position valued at US$6.9M, representing 1.63% of its reported portfolio and ranking #15 among its reported holdings. Cutter & CO Brokerage, Inc. has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q3 2023.

Latest position (Q1 2025)10.84K sh
Reported value held$6.87M
Portfolio Weight1.63%
First reportedQ3 2023
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Cutter & CO Brokerage, Inc.'s REGN position evolved

Cutter & CO Brokerage, Inc. first disclosed a stake in REGN in Q3 2023 at 8,067 shares (US$6.6M). The position peaked in Q2 2024 at 7,776 shares, worth US$8.2M. Across 7 filings, Cutter & CO Brokerage, Inc. increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2025) shows 10,838 shares valued at US$6.9M — an increase of 2,880 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2025 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 8.07K $6.64M New
Q4 2023 7.88K $6.92M Reduce
Q1 2024 7.83K $7.53M Reduce
Q2 2024 7.78K $8.17M Reduce
Q3 2024 7.67K $8.06M Reduce
Q4 2024 7.96K $5.67M Add
Q1 2025 10.84K $6.87M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Cutter & CO Brokerage, Inc. held REGN?

Cutter & CO Brokerage, Inc. has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q3 2023.

What is Cutter & CO Brokerage, Inc.'s current position in REGN?

As of Q1 2025, Cutter & CO Brokerage, Inc. holds 10.84K shares of REGN (REGENERON PHARMACEUTICALS), valued at $6.87M, representing 1.63% of its reported portfolio and ranking #15.

Has Cutter & CO Brokerage, Inc. been buying or selling REGN?

In the latest 13F filing (Q1 2025), Cutter & CO Brokerage, Inc. increased its position in REGN. The position peaked in Q2 2024 at 7.78K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.